ACCELERON PHARMA INC

Profile

Company Names

ACCELERON PHARMA INC

Addresses

128 SYDNEY STREET, CAMBRIDGE, MA 02139

128 SIDNEY STREET, CAMBRIDGE, MA 02139

Phone Numbers

617-649-9200

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$61,674,066.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2013-09-24 
$10,000,005.00 
$10,000,005.00 
$0.00 
Equity 
3
2011-12-22 
$30,472,934.00 
$30,472,934.00 
$0.00 
Equity 
2
2010-06-10 
$10,250,006.00 
$11,500,005.00 
$1,249,999.00 
Equity 
1
2009-12-03 
$10,951,121.00 
$10,951,121.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
PETER 
 
COUROSSI 
EXECUTIVE OFFICER
ACCELERON PHARMA INC   |  KALA PHARMACEUTICALS, INC.   |  TRACT THERAPEUTICS, INC.   |  NOCION THERAPEUTICS, INC.
STEVEN 
 
ERTEL 
EXECUTIVE OFFICER
ACCELERON PHARMA INC
ANTHONY 
 
EVNIN 
DIRECTOR
AVEO PHARMACEUTICALS INC   |  METABOLEX, INC.   |  ACCELERON PHARMA INC   |  BOSTON POWER INC   |  CONSTELLATION PHARMACEUTICALS INC   |  ALTEA THERAPEUTICS CORP   |  JUNO THERAPEUTICS, INC.
ANTHONY 
B 
EVNIN 
DIRECTOR
ACCELERON PHARMA INC
PAT 
 
GAGE 
DIRECTOR
ACCELERON PHARMA INC   |  4820 INGERSOLL HOLDCO, LLC
JEAN 
 
GEORGE 
DIRECTOR
PORTOLA PHARMACEUTICALS INC   |  ACCELERON PHARMA INC   |  CALITHERA BIOSCIENCES, INC.   |  HYDRA BIOSCIENCES INC   |  CATABASIS PHARMACEUTICALS INC   |  THRASOS INNOVATION INC.   |  GEMINI THERAPEUTICS, INC.   |  CYTEIR THERAPEUTICS, INC.
GEORGE 
 
GOLUMBESKI 
DIRECTOR
ACCELERON PHARMA INC   |  KSQ THERAPEUTICS, INC.   |  SHATTUCK LABS, INC.   |  SAGE THERAPEUTICS, INC.   |  CHROMA MEDICINE, INC.   |  JUDO BIO INC.
CARL 
 
GORDON 
DIRECTOR
FARALLON BIOSCIENCES, INC   |  AMNIS CORP   |  IGENICA INC   |  ACCELERON PHARMA INC   |  ARAGON PHARMACEUTICALS, INC.   |  GOOD START GENETICS, INC.   |  ARSANIS, INC.   |  SINGULEX INC   |  SELECTA BIOSCIENCES INC   |  IGENICA BIOTHERAPEUTICS, INC   |  COMPASS THERAPEUTICS LLC   |  ADICET BIO, INC.   |  INTELLIA THERAPEUTICS, INC.   |  ALECTOR LLC   |  GEMINI THERAPEUTICS, INC.   |  SPRINGWORKS THERAPEUTICS, LLC   |  PREVAIL THERAPEUTICS INC.   |  THESEUS PHARMACEUTICALS, INC.   |  TP THERAPEUTICS, INC.   |  KUMQUAT BIOSCIENCES INC   |  PASSAGE BIO, INC.   |  KEROS THERAPEUTICS, INC.   |  ADARX PHARMACEUTICALS, INC.   |  BLOSSOMHILL THERAPEUTICS, INC.   |  SCRIBE THERAPEUTICS, INC.   |  GARUDA THERAPEUTICS, INC.   |  ODYSSEY THERAPEUTICS, INC.   |  ALTEROME THERAPEUTICS, INC.   |  AVENZO THERAPEUTICS, INC.   |  MBX BIOSCIENCES, INC.   |  ARRIVENT BIOPHARMA, INC.   |  BELENOS BIOSCIENCES, INC.   |  LOMOND THERAPEUTICS HOLDINGS, INC.   |  STAR THERAPEUTICS LLC
CARL 
L. 
GORDON 
DIRECTOR
CADUCEUS PRIVATE INVESTMENTS IV, LP   |  AMARIN CORP PLC\UK   |  SELECTA BIOSCIENCES INC   |  CADUCEUS CAPITAL II, L.P.   |  CADUCEUS CAPITAL, L.P.   |  ORBIMED ISRAEL PARTNERS LIMITED PARTNERSHIP   |  ACCELERON PHARMA INC   |  SINGULEX INC   |  SINGULEX, INC.   |  ORBIMED PARTNERS II, L.P.   |  ORBIMED PARTNERS, L.P.   |  ORBIMED PRIVATE INVESTMENTS V, LP   |  ORBIMED GLOBAL HEALTHCARE ASSOCIATES FUND, L.P.   |  ORBIMED GLOBAL HEALTHCARE FUND, L.P.   |  ORBIMED ROYALTY OPPORTUNITIES II, LP   |  ORBIMED ASIA PARTNERS III, L.P.   |  ORBIMED ROYALTY + CREDIT OPPORTUNITIES III, LP   |  ORBIMED GENESIS FUND, L.P.   |  ORBIMED NEW HORIZONS FUND, L.P.   |  COMPASS THERAPEUTICS, INC.   |  ORBIMED ASIA PARTNERS IV, L.P.   |  ORBIMED ASIA PARTNERS V, L.P.   |  ORBIMED ROYALTY + CREDIT OPPORTUNITIES IV, LP   |  ORBIMED RCO IV OFFSHORE FEEDER, LP   |  ORBIMED PRIVATE INVESTMENTS IX, LP   |  ORBIMED RCO V OFFSHORE FEEDER, LP   |  ORBIMED ROYALTY + CREDIT OPPORTUNITIES V, LP   |  ORBIMED ASIA PARTNERS VI, L.P.
ED 
 
KANIA 
DIRECTOR
VISEN MEDICAL INC   |  ACCELERON PHARMA INC   |  TARIS BIOMEDICAL INC   |  INTIO, INC.   |  MEDIDAMETRICS, INC.
EDWIN 
M. 
KANIA 
DIRECTOR
ACCELERON PHARMA INC   |  BLEND THERAPEUTICS, INC.   |  G6 CAPITAL MANAGEMENT, LLC   |  TARVEDA THERAPEUTICS, INC.
EDWIN 
M. 
KANIA, JR. 
DIRECTOR
TRANSMEDICS, INC.   |  ACCELERON PHARMA INC   |  G6 CAPITAL MANAGEMENT, LLC   |  SELECTA BIOSCIENCES INC   |  VYRIAD, INC.
JOHN 
 
KNOPF 
EXECUTIVE OFFICER, DIRECTOR
ACCELERON PHARMA INC
TOM 
 
MANIATIS 
DIRECTOR
ACCELERON PHARMA INC   |  CONSTELLATION PHARMACEUTICALS INC   |  KALLYOPE, INC.
TERRANCE 
G. 
MCGUIRE 
DIRECTOR
IRONWOOD PHARMACEUTICALS INC   |  POLARIS VENTURE PARTNERS VI, L.P.   |  ACCELERON PHARMA INC   |  POLARIS PARTNERS VII, L.P.   |  MICROCHIPS BIOTECH, INC.   |  ADAGIO THERAPEUTICS, INC.   |  BLUE RABBIT VENTURES, INC.   |  JNANA THERAPEUTICS INC.
TERRY 
 
MCGUIRE 
DIRECTOR
CERULEAN PHARMA INC.   |  SUSTAINX INC   |  ACCELERON PHARMA INC   |  PULMATRIX INC   |  ARSENAL MEDICAL, INC.   |  IORA HEALTH, INC.   |  ALECTOR LLC   |  KALLYOPE, INC.   |  ARIVALE INC.   |  QUANTUM DESIGNS, LLC   |  TECTONIC THERAPEUTIC, INC.   |  INVIVYD, INC.
KEVIN 
F. 
MCLAUGHLIN 
EXECUTIVE OFFICER
ACCELERON PHARMA INC
RICHARD 
 
POPS 
DIRECTOR
ACCELERON PHARMA INC
RICHARD 
F. 
POPS 
DIRECTOR
ACCELERON PHARMA INC
JASBIR 
 
SEEHRA 
EXECUTIVE OFFICER
ACCELERON PHARMA INC   |  KEROS THERAPEUTICS, INC.
MATTHEW 
L. 
SHERMAN 
EXECUTIVE OFFICER
ACCELERON PHARMA INC
ROBERT 
 
STEININGER 
EXECUTIVE OFFICER
ACCELERON PHARMA INC
WYLIE 
 
VALE 
DIRECTOR
ACCELERON PHARMA INC
WYLIE 
W. 
VALE 
DIRECTOR
ACCELERON PHARMA INC
JOSEPH 
S. 
ZAKRZEWSKI 
DIRECTOR
PROMEDIOR INC   |  ACCELERON PHARMA INC   |  INVESTABLE EMERGING MARKETS COUNTRY FUND   |  EMERGING (FREE) MARKETS COUNTRY FUND   |  GLIACURE, INC.   |  EMERGING MARKETS COUNTRY FUND   |  CERECIN INC.   |  CYTEIR THERAPEUTICS, INC.   |  AN2 THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2013-09-27
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2013-09-24 
2012-01-04
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-12-22 
2010-07-21
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-06-10 
2010-06-18
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-06-10 
2009-12-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-12-03 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#